FDA NDC Directory · JSON-LD · Markdown

SPEVIGO

NDC 0597-7705 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namespesolimab-sbzo
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761244
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsSPESOLIMAB (300 mg/2mL)
Marketing started20250528
Package count2

External sources

Source: openFDA. Public-domain (CC0).